Antibody Therapeutics for Life

Notices

``Preclinical pharmacokinetics, interspecies scaling, and pharmacokinetics of a Phase I clinical trial of TTAC-0001, a fully human monoclonal antibody against vascular endothelial growth factor 2`` is now indexed on PubMed.
  • Written by Admin
  • Written date 2019-01-14 11:34:07
  • Inquire 1750

Preclinical pharmacokinetics, interspecies scaling, and pharmacokinetics of a Phase I clinical trial of TTAC-0001, a fully human monoclonal antibody 

against vascular endothelial growth factor 2" is now indexed on PubMed.

 

 

PharmAbcine, a clinical stage immune-oncology company, today announced that "Preclinical pharmacokinetics, interspecies scaling, and 

pharmacokinetics of a Phase I clinical trial of TTAC-0001, a fully human monoclonal antibody against vascular endothelial growth factor 2"

is now indexed on PubMed.

 

Link to your paper on PubMed: http://www.ncbi.nlm.nih.gov/pubmed/29563774

List





Prev Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited ...
Next `` Evaluation of drug mechanism and efficacy of a novel anti-angiogenic agent, T...